ERBB2 and neoplasm: However, no significant correlations were found with other clinicopathological characteristics, such as patient age, tumor side (left/right breast), tumor size, pathological staging, ER status, PR status, HER2 status, Ki-67 level, molecular subtype, androgen receptor status (AR), and vascular invasion (Table 1).